These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9169307

  • 1. The effects of antidepressants on psychomotor function with particular reference to reboxetine.
    Hindmarch I.
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S17-21; discussion S71-3. PubMed ID: 9169307
    [Abstract] [Full Text] [Related]

  • 2. The role of norepinephrine in the treatment of depression.
    J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985
    [No Abstract] [Full Text] [Related]

  • 3. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA.
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.
    Hajós M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EH.
    CNS Drug Rev; 2004 Apr; 10(1):23-44. PubMed ID: 14978512
    [Abstract] [Full Text] [Related]

  • 8. The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
    Brunnauer A, Laux G, David I, Fric M, Hermisson I, Möller HJ.
    J Clin Psychiatry; 2008 Dec; 69(12):1880-6. PubMed ID: 19203476
    [Abstract] [Full Text] [Related]

  • 9. Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
    Massana J.
    J Clin Psychiatry; 1998 Dec; 59 Suppl 14():8-10. PubMed ID: 9818624
    [Abstract] [Full Text] [Related]

  • 10. [SSRI resistant depression. Supplementation with noradrenergic pharmaceuticals can be a good alternative].
    Bodlund O, Häggström L.
    Lakartidningen; 2004 Sep 02; 101(36):2712-4. PubMed ID: 15455633
    [Abstract] [Full Text] [Related]

  • 11. Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.
    Moeller O, Hetzel G, Michael N, Rothermundt M, Arolt V, Erfurth A.
    Neuropsychobiology; 2005 Sep 02; 51(2):67-71. PubMed ID: 15741746
    [Abstract] [Full Text] [Related]

  • 12. Antidepressant effectiveness in severe depression and melancholia.
    Schatzberg AF.
    J Clin Psychiatry; 1999 Sep 02; 60 Suppl 4():14-21; discussion 22. PubMed ID: 10086479
    [Abstract] [Full Text] [Related]

  • 13. [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline].
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):56. PubMed ID: 15526675
    [No Abstract] [Full Text] [Related]

  • 14. Do noradrenaline and serotonin differentially affect social motivation and behaviour?
    Dubini A, Bosc M, Polin V.
    Eur Neuropsychopharmacol; 1997 Apr 08; 7 Suppl 1():S49-55; discussion S71-3. PubMed ID: 9169310
    [Abstract] [Full Text] [Related]

  • 15. The need for new and better antidepressants: reboxetine a new option.
    Dencker SJ.
    Acta Psychiatr Scand Suppl; 2000 Apr 08; 402():6-11. PubMed ID: 10901153
    [Abstract] [Full Text] [Related]

  • 16. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
    Dubini A, Bosc M, Polin V.
    J Psychopharmacol; 1997 Apr 08; 11(4 Suppl):S17-23. PubMed ID: 9438229
    [Abstract] [Full Text] [Related]

  • 17. [Reboxetine (Edronax)].
    Souery D, Sternon J.
    Rev Med Brux; 1999 Dec 08; 20(6):511-6. PubMed ID: 10672775
    [Abstract] [Full Text] [Related]

  • 18. Chairman's overview. The place of reboxetine in antidepressant therapy.
    Montgomery SA.
    J Clin Psychiatry; 1998 Dec 08; 59 Suppl 14():26-9. PubMed ID: 9818628
    [Abstract] [Full Text] [Related]

  • 19. Norepinephrine involvement in antidepressant action.
    Frazer A.
    J Clin Psychiatry; 2000 Dec 08; 61 Suppl 10():25-30. PubMed ID: 10910014
    [Abstract] [Full Text] [Related]

  • 20. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.
    Andreoli V, Caillard V, Deo RS, Rybakowski JK, Versiani M.
    J Clin Psychopharmacol; 2002 Aug 08; 22(4):393-9. PubMed ID: 12172339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.